Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor
U. Vanhoefer, José Baselga(Harvard University), Tanja Trarbach(Virginia Cancer Institute), J. Tillner, Mitra Tewes, Olaf Dirsch(Unfallkrankenhaus Berlin), Federico Rojo(Hospital Universitario Fundación Jiménez Díaz), Oliver Rosen, S. Seeber, Ada Braun(National Cancer Centre Japan), A. Harstrick(Merck KGaA, Darmstadt (Germany)), Andreas Kovar, N. Schleucher
Cited by 259
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
|Genome Research|2011|2k
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer
|JNCI Journal of the National Cancer Institute|2007|876